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Abstract
Background: The role of circulating complement in host defense and immune disease is well established. Although a
number of cells and tissues are capable of synthesizing complement components locally, the importance of such local
synthesis in immune disease has been difficult to establish.
Methodology/Principal Findings: We used bone marrow transplantation (BMT) between C3 knockout (C3KO) and wild type
(WT) mice to construct animals that were discordant for systemic (hepatic) and local (monocytic) C3 synthetic capacity. An
immune complex glomerulonephritis (GN) was then induced using intraperitoneal injections of horse spleen apoferritin
(HSA) with a lipopolysaccharide (LPS) adjuvant. All HSA/LPS animals developed a proliferative GN with glomerular
infiltration by monocytes. By sensitive ELISA, monocyte C3 synthesis could be detected in C3KO animals transplanted with
WT bone marrow cells. Despite this, there were no significant differences among groups of mice in measures of clinical
(proteinuria, renal function) or histologic (glomerular cellularity, crescents) disease severity.
Conclusions/Significance: In this model of GN, local synthesis of C3 by infiltrating cells does not appear to be of pathologic
importance.
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Introduction
The complement proteins are major effectors of inflammation
in glomerulonephritis, both in humans and in animal models. The
bulk of complement deposited in the glomerulus in acute
glomerulonephritis is presumed to come from the circulation,
and is synthesized in the liver. This constitutes ‘‘systemic’’
complement synthesis.
A variety of other cells, however, are capable of synthesizing
complement components. Most of these are epithelial; we have
shown that renal proximal tubule epithelial cells (PTEC)
synthesize a variety of components in humans and mice [1–3].
There is also good evidence that hematopoietic cells of the
monocyte/macrophage lineage synthesize a variety of comple-
ment components, both in vivo and in vitro [4]. Recent work has
suggested that monocyte-derived C3 may be important in the local
immune response in the reticuloendothelial system [5]. This, in
turn, constitutes ‘‘local’’ complement synthesis.
Many glomerulopathies are characterized by a mononuclear
cell infiltrate. It has been suggested that complement synthesized
by these infiltrating cells could be an important mediator of
glomerular injury [6].
Although we have reported several studies addressing the role of
locally synthesized complement by tubular epithelium in the renal
interstitium [1–3,7], the role of monocyte-derived complement in
the glomerulus has not been addressed. In the experiments
reported herein, we employ a novel strategy by which animals
deficient in C3 undergo hematologic reconstitution with bone
marrow from C3 replete animals. This strategy makes it possible to
separate the contribution of systemic (liver-derived) complement
from that potentially produced by monocytes.
Materials and Methods
Experimental Animals
C57BL/6 mice, either wild type (WT) or homozygous C3
knockout (C3KO), were purchased from The Jackson Labs (Bar
Harbor, ME). The protocol was reviewed and approved by the
Committee for the Humane Use of Animals at SUNY Upstate
Medical University.
Creation of chimeras by bone marrow cell (BMC)
transplantation
Eight week old male mice were irradiated with 11 Gray, a lethal
dose which is split into two half doses delivered four hours apart.
Such a dose regime avoids a substantial amount of gut induced
radiation disease, and minimizes gastric distress. To prevent death
from nasal pseudomonas, twenty-four hours prior to, and for one
week after irradiation, the animals were given tetracycline
(6.5 mg/ml terramycin in acidified water, administered ad
libitum). On the day following irradiation, each animal received
approximately four million bone marrow cells (BMC) that had
been harvested by flushing the marrow cavity of femurs and tibiae
of donor WT or C3KO mice with DMEM (Invitrogen, Carlsbad,
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Logan, UT). The BMC were washed several times with PBS and
then contaminating red blood cells were lysed with AKC buffer
(0.15 M NH4CL, 10 mM KHCO3 and 0.1 mM EDTA,
pH 7.35). The BMC were washed, resuspended in DMEM,
counted, and injected intravenously via a tail vein using a 26-
gauge needle.
The chimeras created by this process were defined as follows:
WT
IR/WT–WT background irradiated, reconstituted with
WT bone marrow cells
WT
IR/C3KO–WT background irradiated, reconstituted
with C3KO bone marrow cells
C3KO
IR/WT–C3KO background irradiated, reconstituted
with WT bone marrow cells
C3KO
IR/C3KO–C3KO background irradiated, reconstitut-
ed with C3KO bone marrow cells
The first and fourth groups served as controls for the processes
of irradiation and reconstitution.
Induction of glomerulonephritis
The irradiated and transplanted animals were allowed to
recover for 4 weeks, at which time immune complex glomerulo-
nephritis was induced using a method we have described
previously [3]. Briefly, 10 mg horse spleen apoferritin (HSA;
Sigma, St. Louis) were injected intraperitoneally (IP) five days per
week. One hundred micrograms lipopolysaccharide (LPS; from
Salmonella minnesota; EMD Biosciences, La Jolla, CA) were
delivered by the same route three days per week as adjuvant.
Each group of transplanted animals was composed of six male
mice who were approximately 12 weeks old at the time of
induction of glomerulonephritis. Additional groups of six WT and
six C3KO animals (also 12 weeks old ) served as vehicle control
groups and received 0.2 ml injections of 150 mM NaCl, IP, five
days per week. All six groups of mice were injected by this protocol
for a total of six weeks.
Harvesting of tissues
Nine weeks after starting injection, animals were euthanized by
CO2 narcosis. For 24 hours prior to euthanasia, they were placed
in metabolic cages for collection of urine. Immediately after death,
blood was obtained by vena cava puncture, and tissue was
obtained from kidney and spleen. Some tissue samples were place
in 10% buffered formalin. American Histolabs, Inc., (Gaithers-
burg, MD), performed embedding, sectioning and staining with
either hematoxylin and eosin, or periodic acid-Schiff (PAS) stain
for histology. Additional tissue samples were quick frozen in M-1
embedding matrix (Thermo Shandon, Pittsburgh, PA) for
immunohistochemistry.
Histological analysis of kidney sections
A series of digital images representing the complete cortex from
a periodic acid-Schiff-stained kidney section from each animal was
collected with a SPOT Diagnostics camera (Sterling Heights, MI),
as we have previously described [7]. These images were then
analyzed for the following measures:
& Glomerular cellularity, defined as the total cells in ten
representative glomerular cross sections.
& Glomerular crescents, defined as two or more cell layers
surrounding the glomerular tuft, in 50 glomeruli.
Immunohistochemistry of kidney sections
Frozen sections of kidneys were thawed slowly and washed with
PBS, followed by incubation with either 10% normal goat serum
(for C3c slides) or 10% normal rat serum (for CD14 slides) for
30 minutes at 37uC. Excess serum was blotted and the slides were
incubated for one hour at 37uC with either goat anti-mouse C3c
with a FITC label (Nordic Immunology/Accurate Chemical,
Westbury, NY), or rat anti-mouse CD14 (eBioscience, San Diego,
CA), both antibodies diluted in PBS. Slides were again washed
with PBS, and the CD14 slides were incubated with goat anti-rat
IgG–FITC (Jackson ImmunoResearch, West Grove, PA) for an
additional 30 minutes at 37uC. Following incubation with
antibodies, slides were washed with PBS and then mounted with
0.1% o-phenylenediamine in PBS-glycerol.
Plasma C3 concentration
The concentration of C3 in the plasma was measured by Mouse
High-Sensitive Complement C3 ELISA (Kamiya Biomedical
Company, Seattle, WA), following manufacturer’s directions. For
this double antibody sandwich ELISA, samples from WT
background mice were diluted 1:50,000, and samples from
C3KO background mice were diluted 1:50.
Results
Chimeras
The bone marrow transplantation process created chimeras that
survived to undergo the injection protocol. Examination of
peripheral blood smears and reticuloendothelial structures (spleen)
of selected animals confirmed hematologic reconstitution (Figure 1).
Clinical disease
All animals receiving HSA/LPS developed proteinuria
(Table 1). There were no significant differences in the quantity
of urine protein among the four groups of chimeras. There were
also no significant differences among the chimera groups in renal
function, as assessed by measurements of blood urea nitrogen, and
plasma albumin and creatinine, at the time of harvest (Table 1).
Glomerular histology and immunohistochemistry
All animals receiving HSA/LPS injections developed a
proliferative glomerulonephritis (HSA/LPS treated mice are
shown in Figure 2c–f) as compared to a WT and C3KO mouse
treated with saline shown in Figure 2a–b. FITC-conjugated anti-
CD14 staining demonstrated that the predominate cell type
infiltrating the glomeruli was monocytes (Figure 3c–f). Background
staining of CD14 in either a WT or a C3KO mouse treated with
saline is shown is Figure 3a–b. As we have shown previously in
intact animals [3], there was evidence of C3 glomerular deposition
in each chimera with a wild type background (WT
IR/WT and
WT
IR/C3KO; Figure 4). As objective measures of the severity of
glomerular inflammation, glomerular cell counts and crescent
formation were determined for each animal, and among group
comparisons made. There were no differences in either measure of
nephritic severity among the chimera groups (Table 2).
Plasma C3 concentration
Plasma C3 concentrations in the experimental animals are
shown in Figure 5. There were no significant differences in
concentration between the chimeras with WT backgrounds
(WT
IR/C3KO and WT
IR/WT). On the other hand, when
C3KO animals were reconstituted with WT bone marrow cells,
detectable C3 was present in plasma, albeit at only a fraction
Nephritis in C3 Knockout Mice
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C3KO
IR/C3KO chimeras had C3 concentrations below
0.001 mg/ml, approaching the lower limit of the assay.
Discussion
Several lines of evidence support a role for the complement
system in many forms of glomerulonephritis [8]. Complement
componentscanbeshowntobedepositedwithinaffected glomeruli.
The concentration of many complement components in plasma is
reduced during active glomerulonephritis, and circulating comple-
ment component breakdown products can be detected.
The liver is the source of most circulating complement. For
several years, however, it has been appreciated that there is
extrahepatic synthesis of a variety of components, both in humans
and in experimental animals [9]. The in vivo importance of this,
however, remains unclear. In a model of murine herpes virus
infection, for example, local complement synthesis and activation
in the myeloid compartment has been shown to enhance the
development of humoral immunity [5]. This effect may be
mediated via C3a binding to bone marrow dendritic cells, since
inhibition of such binding impairs T cells response to antigen
presented by those cells 10]. In vitro, PTEC with bound C3b
enhanced alloreactive T cell activation [11].
A number of published studies of extrahepatic complement
synthesis have dealt with the kidney and monocytes. Renal
complement synthesis was first demonstrated in lupus-prone
(NZB) mice by Passwell and colleagues [9]. Subsequently, our
laboratory established that the renal proximal tubular epithelium
was the source of kidney mRNA for complement components, in
both humans and mice [1–3]. This observation paralleled other
studies of renal tubular epithelial cells in vitro [12,13].
The role of this tubular complement synthesis has been
examined in experimental animals, based upon observations in
human disease. Chronic glomerulonephritis that progresses to
ESRD is always accompanied by tubulointerstitial disease:
peritubular edema, fibrosis, inflammatory cell infiltration, and
tubular atrophy. We have employed experimental animals models
to support an important role for such tubular complement
component synthesis in tubulointerstitial disease [3,14]. There is
also experimental evidence of a role for local renal C3 synthesis in
reperfusion injury [15]. Alternative pathway complement activa-
tion and occupation of the C3a receptor on proximal tubular
epithelial cells promotes cytokine expression in a murine
reperfusion model [16].
The in vivo role of monocyte-derived complement, specifically
C3, has been studied much less. Studies in C3KO
IR/WT
chimeras, similar to those we have employed, have suggested a
role for local (presumably monocyte/macrophage-derived) C3 in
the reticuloendothelial system in the immune response to viruses
[5]. This study, as is the case in ours, showed evidence of some
low-level C3 present in plasma as well. Conversely, other studies
have suggested a role for C3 in the differentiation of monocytes
into dendritic cells [17].
The synthesis of monocyte C3 and other complement proteins
could theoretically be important in the glomerular component of
glomerulonephritis. Many glomerulonephritides, both in humans
and in animal models, are characterized by monocytic infiltrate. In
vitro, monocyte C3 synthesis is enhanced by stimuli such as
Figure 1. Confirmation of hematologic reconstitution of mice
that were lethally irradiated and then transplanted with donor
bone marrow cells; magnification,6100. a: Wright-Giemsa stained
peripheral blood smear from a C3KO animal 14 weeks after bone
marrow transplant from a WT mouse. Note presence of all three cell
lines (erythrocytes, leukocytes, platelets). b: Hematoxylin and eosin
stained spleen section from a C3KO mouse 14 weeks after transplan-
tation from a WT animal. Note normal appearing lymphatic nodules.
doi:10.1371/journal.pone.0003334.g001
Table 1. Comparison of the degree of proteinuria and the status of renal function following induction of glomerulonephritis in
chimeric mice versus saline injected controls.
Urine Albumin (mg/ml) Blood Urea Nitrogen (mg/dl) Plasma Creatinine (mg/dl) Plasma Albumin (g/dl)
WT-Saline 24.567.9
a 23.561.2 0.2760.02 2.7860.18
C3KO-Saline 47.269.9
+ 27.261.9 0.2260.02 3.0760.26
WT
IR/WT 604.56157.9 53.763.4 0.4360.02 2.5560.03
WT
IR/C3KO 604.26170.2 49.7612.9 0.4060.05 2.5060.10
C3KO
IR/WT 599.56277.0 38.866.8 0.3260.04 2.3360.28
C3KO
IR/C3KO 613.76145.9 92.0636.29 0.4560.15 2.6360.13
aMean6S.E.M.
+P=0.102 vs. WT-Saline.
doi:10.1371/journal.pone.0003334.t001
Nephritis in C3 Knockout Mice
PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3334cytokines [4] and immune complexes [6]. Obviously, both of these
stimuli may be in abundance in glomeruli affected by immune
complex glomerulonephritis. Thus, it is reasonable to hypothesize
that infiltrating monocytes could amplify the inflammatory process
by providing a source of local C3.
Testing this hypothesis in intact animals would be difficult. The
presence of circulating liver-derived C3 in plasma would make it
impossible to establish the presence of what would likely be
quantitatively smaller amounts of locally synthesized protein.
Moreover, the known strong in situ hybridization signal from tubular
C3 mRNA could overwhelm a weaker glomerular signal [3].
To overcome this problem, we employed the construction of
‘‘chimeras’’, similar to work done by Verschoor et al. who studied
the immune response to herpes virus [5]. This strategy permitted
us to induce immune complex glomerulonephritis in animals
lacking normal systemic C3 synthetic capability, but with a
hematopoietic system reconstituted from wild type mice.
As we have noted previously, the glomerulonephritis model we
have employed resulted in marked glomerular hypercellularity.
Using immunofluorescent techniques, we demonstrated that much
of this hypercellularity is derived from infiltrating monocytes.
Additionally, animals with wild type background had evidence of
Figure 2. Histology of kidney sections. All sections were stained with Periodic Acid-Schiff stain; magnification 6400. a: WT mouse treated with
saline. b: C3KO mouse treated with saline. c: WT
IR/WT mouse treated with HSA/LPS. d: C3KO
IR/WT treated with HSA/LPS. e: WT
IR/C3KO mouse
treated with HSA/LPS. f: C3KO
IR/C3KO treated with HSA/LPS.
doi:10.1371/journal.pone.0003334.g002
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shown such deposits of C3 in the glomerulus, beginning at about
three weeks after induction of glomerulonephritis [3]. Although
some plasma C3 could be detected in C3KO
IR/WT chimeric
mice, they did not have immunohistochemical evidence of
glomerular C3 deposition.
As would be expected from the work of Drouin and colleagues
[4], monocytes from these animals should express C3 mRNA
following cytokine stimulation. The presence of detectable C3
protein by ELISA in the plasma collected from our C3KO
IR/WT
chimeric mice confirms this, although the concentration is unlikely
to be physiologically important. Some workers have suggested a
role for C3 synthesis by monocytes in local inflammatory
conditions such as glomerulonephritis and transplant rejection
[18,19]. Two lines of evidence in the studies reported herein
suggest that such an effect is either nonexistent or trivial.
First of all, immunohistochemistry for C3 in C3KO animals
reconstituted with WT bone marrow cells shows no C3 glomerular
deposition, despite active inflammation and trace C3 protein in
infiltrating cells. Such experiments are critical to establishing this,
since the strong C3 deposition in C3 replete (i.e. WT) mice would
overcome any locally synthesized proteins.
The other important observations relate to the severity of the
histologic and clinical disease. There was no difference in two
histologic markers of severity (glomerular cell counts and crescents)
between C3KO and WT animals, regardless of whether they were
reconstituted with WT or C3KO bone marrow cells. Furthermore,
there was no difference among groups in proteinuria or renal
function. The glomerular histology in these animals did not differ
from our previously published observations in untransplanted
animals [7].
It could be argued that, despite glomerular deposition in WT
animals, C3 is not critical to the glomerular component of this
model. As our previous studies have shown [3], a variety of
inflammatory mediators are likely present in these affected
glomeruli; these are clearly contributing to an exuberant disease
Figure 3. Immunohistochemical localization of CD14. Sections were stained with rat anti-mouse CD14 followed by goat anti-rat IgG labeled
with FITC; magnification 6100. a: WT mouse treated with saline. b: C3KO mouse treated with saline. c: WT
IR/WT mouse treated with HSA/LPS. d:
C3KO
IR/WT mouse treated with HSA/LPS. e: WT
IR/C3KO mouse treated with HSA/LPS. f: C3KO
IR/C3KO mouse treated with HSA/LPS.
doi:10.1371/journal.pone.0003334.g003
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the glomerular lesion appears to be independent of the presence or
absence of systemic C3 synthetic capacity.
The rationale of these studies, however, was to develop a model
that would permit differentiating the effect of systemic synthesis,
activation and deposition of a complement component from that
which is produced locally, in much smaller quantities and mediates
its effects in the immediate microenvironment. Thus, our results
suggest that in our specific model of immune complex glomeru-
lonephritis, neither systemic nor locally synthesized C3 is critical to
the glomerular inflammatory process. A similar bone marrow
transplant strategy could be employed in other models in which
the glomerular role of C3 appeared more critical.
Finally, it should be noted that the focus of these experiments
was exclusively on glomerular and monocytic C3. Our previous
studies have suggested that the importance of locally synthesized
complement is most likely in the tubulointerstitial component of
inflammatory renal disease, where it is synthesized by the renal
tubular epithelium [3].
These studies demonstrate the importance of examining intact
animal models of disease, in addition to in vitro work, when
considering the role of locally synthesized inflammatory mediators.
Although monocytes clearly are capable of synthesizing the central
protein of the complement cascade in response to inflammation,
this ability does not appear to have an important role in vivo.
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